HENDERSON, NV / ACCESSWIRE / October 5, 2018 / Last week, the DEA announced it has taken some cannabidiol off the most restrictive class of controlled substances, a move that allows the sale of the first nonsynthetic, cannabis-derived medicine to win federal approval. This is enormous news for investors in the CBD industry.
It is the first time the agency has removed any type of cannabis from Schedule 1.
That's why we're highlighting Real Brands, Inc. (RLBD). RLBD successfully launched their CBD Pharmacy® brand at the beginning of the year and has not released any news since. After their initial release of these cartridges the company quickly sold out, leading to this scaled up roll out. With that in mind, there is potentially some news coming soon following up on this announcement.
The DEA's recent announcement combined with the growing thirst from blue chip companies to get their piece of the CBD industry makes an up and coming company like RLBD a serious gem.
CBD companies benefiting from the new include: Real Brands, Inc. (RLBD), India Globalization Capital, Inc. (NYSE American: IGC), Aurora Cannabis, Inc. (ACBFF), New Age Beverages Corporation (NBEV), and Canopy Growth Corporation (CGC).
Real Brands, Inc. (RLBD)
Market Cap: $7.5M Share Price: $0.064
Real Brands, Inc. successfully launched CBD Pharmacy® Vape Cartridges in Texas and Florida at the beginning of the year. "We were impressed with the level of initial orders and reorders from South Florida retailers so we have worked with Dragons, Ltd to bring over $100,000 of CBD Pharmacy® Vape Cartridges inventory to support anticipated growth in the South Florida market," said Pearring. "Real Brands, Inc. has begun development of our internet strategy for CBD Pharmacy® Vape Cartridges while Dragons, Ltd has begun exploring distribution and retail partnerships in several major east coast markets."
India Globalization Capital, Inc. (NYSE American: IGC)
Market Cap: $294.24M Share Price: $9.09
IGC announced that it has executed a distribution and partnership agreement for several products including a sugar free, energy drink called 'Nitro G'. IGC plans to create a branded, hemp/CBD-infused version of the formulation that addresses market demand for energy drinks with the inclusion of healthy properties derived from hemp including CBD.
Aurora Cannabis, Inc. (ACBFF)
Market Cap: $8.9B Share Price: $9.35
Micron Waste Technologies Inc. reported positive results from the optimization of the Cannavore™ cannabis waste processing units with Aurora Cannabis Inc.. The Company will now optimize the technology for sub-zero operations, as well as add computerized remote operating capabilities, following which Micron will commence to offer the units commercially.
CV Sciences, Inc. (CVSI)
Market Cap: $471M, current share price: $4.75
CV Sciences, Inc. is a life science company that operates through two segments, specialty pharmaceuticals and consumer products. They focus on developing and commercializing proprietary prescription drugs utilizing synthetic cannabidiol (CBD) as the active pharmaceutical ingredient and is engaged in the development, manufacturing, marketing and sale of consumer products containing plant-based CBD, which is refined into its own proprietary branded products. CV Sciences initial drug candidate (CVSI-007) is a chewing gum that combines CBD and nicotine, which the Company believes has the potential to effectively treat smokeless tobacco use and addiction.
Canopy Growth Corporation (CGC)
Market Cap: $10.85B Share Price: $47.60
Canopy Growth announced that Spectrum Cannabis, the cannabis corporation's wholly owned subsidiary, has partnered with the Ontario Long Term Care Association to pursue the development and implementation of a long-term care medical cannabis study aimed at seniors. Canopy Growth and the OLTCA will recruit a group of long-term care homes to perform the study while evaluating quality of life outcomes, caregiver stress and the economic benefits of cannabis adoption.
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. ACR Communication, LLC, which owns Microcapspeculators.com, is not registered with Finra or any other financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. ACR Communication, LLC [and/or] Microcapspeculators.com does not have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. ACR Communication LLC, which owns Microcapspeculators.com, is compensated for its services in the form of cash-based compensation or in equity in the companies it writes about, or a combination of the two. ACR Communication, LLC has been compensated one thousand dollars cash for this article and four thousand dollars total by Regal Consulting. LLC, for news commentary articles for RLBD. RLBD and Regal Consulting, LLC were given an opportunity to edit information included in this article. This article is based solely on public information and the opinions of ACR Communication, LLC, which believes the news commentary to include accurate and complete information. ACR Communications, LLC. and the hiring party Regal Consulting, LLC. may buy or sell additional shares of RLBD in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.
For Full Legal Disclaimer Click Here.
Regal Consulting, LLC,For Full Legal Disclaimer Click Here.
Company Name: Microcap Speculators
Contact Person: Media Manager
Country: United States
SOURCE: ACR Communication, LLC